Tomotaka Suzuki

671 total citations
56 papers, 463 citations indexed

About

Tomotaka Suzuki is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Tomotaka Suzuki has authored 56 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 12 papers in Hematology. Recurrent topics in Tomotaka Suzuki's work include Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tomotaka Suzuki is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Tomotaka Suzuki collaborates with scholars based in Japan, United States and Singapore. Tomotaka Suzuki's co-authors include Nobuhisa Kanahara, Masaomi Iyo, Hiroyuki Watanabe, Masayuki Takase, Hiroshi Kimura, Dai Maruyama, Shigeru Kusumoto, Shinsuke Iida, Naoto Suda and Suguru Fukuhara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Tomotaka Suzuki

48 papers receiving 458 citations

Peers

Countries citing papers authored by Tomotaka Suzuki

Since Specialization

Citations

This map shows the geographic impact of Tomotaka Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomotaka Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomotaka Suzuki more than expected).

Fields of papers citing papers by Tomotaka Suzuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomotaka Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomotaka Suzuki. The network helps show where Tomotaka Suzuki may publish in the future.

Co-authorship network of co-authors of Tomotaka Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomotaka Suzuki. A scholar is included among the top collaborators of Tomotaka Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomotaka Suzuki. Tomotaka Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunosuppressive Effects of Multiple Myeloma‐Derived Extracellular Vesicles Through T Cell Exhaustion 2025 ·Cancer Science ·(unknown), Masaki Ri, (unknown), (unknown), (unknown), (unknown), Takahiro Nakashima, Arisa Asano, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Ayako Masaki, Hirokazu Komatsu, Shinsuke Iida	0
2	Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma 2025 ·Cancer Science ·(unknown), Masaki Ri, (unknown), Tomoyuki Nakamura, Hirokazu Sasaki, (unknown), Takahiro Nakashima, (unknown), Arisa Asano, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Ayako Masaki, Takaomi Sanda, Kazufumi Yamagata, Kohmei Kubo, Hirokazu Komatsu, Hirotake Sakuraba, Shinsuke Iida	0
3	Prognostic impact of RDI of vincristine in patients with DLBCL receiving R-CHOP: a supplementary analysis of JCOG0601 2025 ·PubMed ·(unknown), Tomotaka Suzuki, Ryunosuke Machida, Kazuyuki Shimada, Tsutomu Kobayashi, Dai Maruyama, Wataru Munakata, Shinsuke Iida, (unknown), Tomohiro Kinoshita, Kiyoshi Ando, (unknown)	0
4	Prevalence of CCR7‐Positive CD8 T Cells as a Prognostic Factor in B‐Cell Maturation Antigen ‐Targeted Chimeric Antigen Receptor T Cell Therapy 2025 ·eJHaem ·(unknown), Masaki Ri, (unknown), (unknown), (unknown), Takahiro Nakashima, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Takaomi Sanda, Hirokazu Komatsu, Shinsuke Iida	0
5	Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B‐cell lymphoma 2025 ·British Journal of Haematology ·Tomotaka Suzuki, (unknown), (unknown), Hirokazu Sasaki, (unknown), Arisa Asano, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Takaomi Sanda, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida, Hiroshi Inagaki	1
6	Low‐dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation 2024 ·Cancer Medicine ·(unknown), Shigeru Kusumoto, Hiroya Hashimoto, (unknown), (unknown), (unknown), Tomotaka Suzuki, Shiori Kinoshita, Masaki Ri, Hirokazu Komatsu, Shinsuke Iida	2
7	Nomogram for predicting survival of patients with diffuse large B-cell lymphoma 2024 ·Annals of Hematology ·(unknown), Atsushi Inagaki, Ayako Masaki, (unknown), Tomotaka Suzuki, Takashi Ishida, Shigeru Kusumoto, Shinsuke Iida, Hiroshi Inagaki	2
8	Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution 2024 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Tomotaka Suzuki, (unknown), (unknown), Aki Kondo, (unknown), (unknown), (unknown), (unknown), (unknown), Shiori Kinoshita, Tomoko Narita, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida	2
9	The Impact of MYD88 and/or CD79B Gene Mutations on Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma 2024 ·Blood ·Tomotaka Suzuki, (unknown), (unknown), Hirokazu Sasaki, (unknown), Arisa Asano, Shiori Kinoshita, Tomoko Narita, Ayako Masaki, Takaomi Sanda, Masaki Ri, Hirokazu Komatsu, (unknown), Hiroshi Inagaki	1
10	Stratifying ‘frail’ Patients Defined By the Simplified Frailty Scale in Multiple Myeloma: Correlation with Clinical Outcomes 2024 ·Blood ·(unknown), Tomotaka Suzuki, (unknown), (unknown), (unknown), Takashi Kanamori, Takashi Yoshida, (unknown), (unknown), Hiroki Yano, Hirokazu Sasaki, Arisa Asano, (unknown), Tomoko Narita, Takaomi Sanda, Masaki Ri, Hirokazu Komatsu, (unknown)	1
11	Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma 2023 ·International Journal of Hematology ·Yoko Nakanishi, (unknown), Masaki Ri, Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Shigeru Kusumoto, Hirokazu Komatsu, Shinsuke Iida	4
12	Impact of Progression-Free Survival at 24 Months on Subsequent Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Supplementary Analysis of JCOG0601 2023 ·Blood ·Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa, Tomotaka Suzuki, Kazuyuki Shimada, Tsutomu Kobayashi, (unknown), Tomohiro Kinoshita, Kiyoshi Ando, Dai Maruyama, Hirokazu Nagai	0
13	Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients 2022 ·Hematological Oncology ·Arisa Asano, Masaki Ri, Ayako Masaki, Yasuhiro Maeda, (unknown), (unknown), (unknown), Takahiro Nakashima, (unknown), Shiori Kinoshita, Tomotaka Suzuki, Tomoko Narita, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Shinsuke Iida	3
14	Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation 2022 ·International Journal of Hematology ·Shiori Kinoshita, Hirokazu Komatsu, (unknown), Takashi Yoshida, Tomotaka Suzuki, Tomoko Narita, (unknown), Masaki Ri, Shigeru Kusumoto, Shinsuke Iida	0
15	Paraneoplastic Pemphigus Associated with B-cell Chronic Lymphocytic Leukemia Treated with Ibrutinib and Rituximab 2018 ·Internal Medicine ·Yuta Ito, Shinichi Makita, Akiko Miyagi Maeshima, Shunsuke Hatta, Tomotaka Suzuki, (unknown), Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Koji Izutsu	14
16	First-episode psychosis in treatment-resistant schizophrenia: a cross-sectional study of a long-term follow-up cohort 2018 ·BMC Psychiatry ·Nobuhisa Kanahara, (unknown), Tomotaka Suzuki, Masayuki Takase, Masaomi Iyo	7
17	Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016 2017 ·International Journal of Hematology ·Akiko Miyagi Maeshima, Hirokazu Taniguchi, Tomotaka Suzuki, (unknown), (unknown), Nobuhiko Yamauchi, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Dai Maruyama, Yukio Kobayashi, Kensei Tobinai	11
18	CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma 2014 ·International Journal of Hematology ·Tomotaka Suzuki, Shigeru Kusumoto, Ayako Masaki, Takashi Ishida, Hiroshi Inagaki, Shinsuke Iida, Fumiko Mori	2
19	Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NF?-B ligand (RANKL) 2004 ·Journal of Bone and Mineral Metabolism ·Tomotaka Suzuki, Naoto Suda, Kimie Ohyama	22
20	[A case control study of breast cancer, mammary cyst and dietary, drinking or smoking habit in Japan]. 1990 ·PubMed ·Shogo Kikuchi, N. Okamoto, Tomotaka Suzuki, (unknown), Hirokazu Nagai, (unknown), Osamu Wada, Yutaka Inaba	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact